Focused ultrasound neuromodulation has been successfully used to affect the memory behavior of macaque monkeys, potentially bringing us one step closer to mapping the human brain.
Focused Ultrasound Foundation Chairman, Neal F. Kassell, MD, was the keynote speaker at Analyst & Investor Day, a first-of-its-kind gathering in the field of focused ultrasound.
The diffusion or adoption of a new therapeutic medical device technology occurs exponentially, and the field of focused ultrasound, which has been gathering momentum and growing at a rate that has vastly exceeded any of our expectations, is proving to be no exception.
Sherry Sharp founded the Rick Sharp Alzheimer’s Foundation in memory of her husband and supports research for Alzheimer’s disease and other conditions.
A recent Baltimore Sun article includes interviews with two of the first patients in a clinical trial using focused ultrasound to treat neuropathic pain.
Scientists and physicians from around the world convened at AACR 2019 in Atlanta, Georgia, to learn about the latest discoveries across the spectrum of cancer research.
The Society for Neuro-Oncology (SNO) will hold its first conference on brain metastases, providing an opportunity to share focused ultrasound work with others in the metastatic brain cancer community.
Researchers explored using focused ultrasound to precisely deliver drugs carried in nanoparticles as an alternative to current oncologic, neurologic, and cardiovascular therapies.
Ann Arbor-based HistoSonics announced that it has closed on a venture capital funding round of $54 million for its focused ultrasound therapy (histotripsy), which destroys cancer tumors. The investment, led by two healthcare heavyweights – Varian Medical Systems and Johnson & Johnson Innovation – is believed to be the second-largest funding round for a medical device company in Michigan history.
